Sign in →

Test ID BRIVA Brivaracetam, Plasma

Method Name

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)


Specimen Required


Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube:

Preferred: Lavender top (K2 EDTA)

Acceptable: Lavender top (K3 EDTA), green top (sodium or lithium heparin), light-blue top (sodium citrate)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. Draw blood immediately before next scheduled dose.

2. For sustained-release formulations only, draw blood a minimum of 12 hours after last dose.

3. Within 2 hours of collection, centrifuge and aliquot plasma into a plastic vial.


Reporting Name

Brivaracetam, P

Specimen Type

Plasma EDTA

Specimen Stability Information

Specimen Type Temperature Time
Plasma EDTA Refrigerated (preferred) 28 days
  Ambient  28 days
  Frozen  28 days

Report Available

Same day/1 to 2 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

LOINC Code Information

Test ID Test Order Name Order LOINC Value
BRIVA Brivaracetam, P 88894-1

 

Result ID Test Result Name Result LOINC Value
620767 Brivaracetam, P 88894-1

Forms

If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:

-Neurology Specialty Testing Client Test Request (T732)

-Therapeutics Test Request (T831)

Useful For

Assessing compliance and toxicity for brivaracetam

Day(s) Performed

Monday through Friday

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

80299

Specimen Minimum Volume

0.5 mL

Reference Values

0.2-2.0 mcg/mL